New York Times: There's more than a dozen experimental weight medications in development.
Vous n'êtes pas connecté
Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful than those currently on the market. Dani Blum, a Well reporter, explains.
New York Times: There's more than a dozen experimental weight medications in development.
centerbCould diabetes and weight-loss drugs hold the key to fighting cancer?/b/center Surprisingly, yes! Diabetes and weight loss medications
centerbCould diabetes and weight-loss drugs hold the key to fighting cancer?/b/center Surprisingly, yes! Diabetes and weight loss medications
Weight-loss surgery significantly reduces the risk of psychiatric issues like cognitive decline, anxiety, and substance use compared to GLP-1...
During an appearance on the Just Trish podcast, Lizzo admitted to using Ozempic and other GLP-1 medication at a certain point in her weight loss...
Bagsværd, Denmark, 21 June 2025 – Novo Nordisk today presented the results from the phase 3b STEP UP trial in people with obesity without...
Bagsværd, Denmark, 21 June 2025 – Novo Nordisk today presented the results from the phase 3b STEP UP trial in people with obesity without...
Weight loss surgery has long been an effective treatment for the more than 40 percent of American adults struggling with obesity.
Weight loss surgery has long been an effective treatment for the more than 40 percent of American adults struggling with obesity.
Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.